Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MPTP-induced mouse model of Parkinson’s disease: A promising direction of therapeutic strategies
Che Norma Mat Taib, Musa Mustapha
Bosnian Journal of Basic Medical Sciences (2020)
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

Implications of Gut Microbiota in Neurodegenerative Diseases
Haoming Zhang, Yijia Chen, Zifan Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 102
Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases
Mathew George, Matthan Tharakan, John Culberson, et al.
Ageing Research Reviews (2022) Vol. 82, pp. 101756-101756
Closed Access | Times Cited: 97
Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
Eui-Hwan Choi, Mi-Hye Kim, Sun-Ji Park
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7952-7952
Open Access | Times Cited: 18
Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
Chunmei Ma, Ying Liu, Sheng Li, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 7, pp. 2018-2035
Open Access | Times Cited: 25
ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102327-102327
Closed Access | Times Cited: 13
Advances in fluorescent probe development for bioimaging of potential Parkinson's biomarkers
Xiaoqian Sun, Qingqing Jiang, Yu Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116195-116195
Closed Access | Times Cited: 11
Unraveling brain diseases: The promise of brain-on-a-chip models
Letizia Cerutti, Martina Brofiga
Journal of Neuroscience Methods (2024) Vol. 405, pp. 110105-110105
Open Access | Times Cited: 8
Ginkgolide B regulates apoptosis, oxidative stress, and mitochondrial dysfunction in MPP+-induced SK-N-SH cells by targeting HDAC4/JNK pathway
Ding Xu, Dongming Tan, Zhao Wang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway
Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier
Cells (2021) Vol. 10, Iss. 2, pp. 230-230
Open Access | Times Cited: 50
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10161-10161
Open Access | Times Cited: 46
Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites
Ziying Jiang, Xinyu Wang, Haoqiang Zhang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 21
Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting
Prajakta Teli, Vaijayanti Kale, Anuradha Vaidya
Cell and Tissue Research (2023) Vol. 394, Iss. 1, pp. 75-91
Closed Access | Times Cited: 18
A naturally occurring variant of SHLP2 is a protective factor in Parkinson’s disease
Su‐Jeong Kim, Brendan Miller, Nicolas Hartel, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 2, pp. 505-517
Open Access | Times Cited: 6
Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and ferroptosis in Parkinson's disease
Xiaomin Fu, Le Qu, Huamin Xu, et al.
Experimental Neurology (2024) Vol. 375, pp. 114724-114724
Closed Access | Times Cited: 6
Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review
Yingfan Chen, Zhenhui Wu, Shaodan Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1053-1081
Open Access | Times Cited: 6
Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
Camila de Oliveira Vian, Marcelo Augusto Germani Marinho, Magno da Silva Marques, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 3-22
Open Access | Times Cited: 6
A review of MPTP-induced parkinsonism in adult zebrafish to explore pharmacological interventions for human Parkinson’s disease
E. E. Bagwell, Jessica Larsen
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson’s disease models
Liling Delila, Ouada Nebie, Nhi Thao Ngoc Le, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 6
Brain-on-a-chip: an emerging platform for studying the nanotechnology-biology interface for neurodegenerative disorders
Raquel O. Rodrigues, Su-Ryon Shin, Manuel Bañobre‐López
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models
Teresa R. Kee, Pamela Espinoza, Jessica L. Wehinger, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 38
Hydrogen Sulfide (H2S) Signaling as a Protective Mechanism against Endogenous and Exogenous Neurotoxicants
Michael Aschner, Anatoly V. Skalny, Tao Ke, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 10, pp. 1908-1924
Open Access | Times Cited: 27
Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson’s Disease
Ramesh Pariyar, Tonking Bastola, Dae Ho Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2388-2388
Open Access | Times Cited: 26
Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson′s disease
Haiyang Yu, Tong Sun, Zhen Wang, et al.
Neural Regeneration Research (2022)
Open Access | Times Cited: 26
Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
Noor Azzizah Omar, Jaya Kumar, Seong Lin Teoh
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
Levodopa Improves Behavioral Deficits of Mice with Parkinson's Disease Symptoms via Curbing NLRP3 Inflammasome Activation and Enhancing Tyrosine Hydroxylase Levels in the Striatum and Substantia Nigra
Xi Chen, Zhao Wang, Weihua Yang, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 1, pp. 2-2
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top